Navigation Links
Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
Date:6/4/2008

HAE:TSX

MONTREAL, June 4 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, announces that it has started processing plasma in its new fractionation facility for the production of its proprietary all-human fibrin sealant for pivotal Phase II/Phase III clinical trials, leading to commercial launch.

Haemacure has reached an important milestone this week with the commencement of plasma fractionation in its new manufacturing facility. Haemacure also confirms that it is on schedule and on budget to produce clinical material during the third quarter of 2008 and file an amendment to its existing IND with the U.S. Food and Drug Administration during the fourth quarter of 2008, in order to begin clinical trials in the first quarter of 2009.

The new fractionation facility incorporates the Hynetics(R) single-use bio-processing plastic containers technology, which has resulted in significant savings in capital expenditures and will also result in significant savings in operating costs, as compared to a stainless steel facility. The use of this technology also minimizes the risks of cross-contamination between production batches.

"Now that our fractionation facility is operational and that we have started processing plasma, Haemacure is truly engaged in its transformation from a development to a manufacturing company." said Joseph Galli, Chairman and CEO of Haemacure. "The upcoming availability of clinical material will enable Haemacure to pursue its clinical plans in hemostasis and to expand into additional indications, such as adhesion prevention." concluded Mr. Galli.

About Haemacure

Haemacure Corporation is a specialty biotherapeutics company developing high-value human plasma-derived protein products for commercialization. Haemacure's research and develop
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
3. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
6. Haemacure Reports on its annual general and special meeting of shareholders
7. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
8. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
9. Haemacure financing receives shareholder consent - Series B Warrants are amended
10. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Newswire-FirstCall/ - Hard To Treat Diseases (HTDS...ovartis, a US$41 billion international healthcare ...accine partner, Zhejiang Tianyuan Bio-Pharmaceutic...zerland will begin a five-year, $1 billion China i...ally increase its investment in its China R&D ...
(Date:11/9/2009)...w may be too late when it comes to preventing or i...lub, Inc. (Take Off Pounds Sensibly), the nonprofi... (Vocus) November 9, 2009 -- Tomorrow ...roving a diabetes condition, according to TOPS Clu...weight-loss support organization., , ,Diabetes is ...
(Date:11/9/2009)...dy highlights positive influence of sports partici...osemont, IL (Vocus) November 9, 2009 -- As people ...Recent research has highlighted the importance of ...hese issues. However, a new study published in the...idisciplinary Approach reveals that there may be ...
(Date:11/9/2009)...9 Actress Mariska Hargitay and the... on Saturday to raise awareness about the need for...ifornia by building healing and wellness kits for ...d to give one to each of the estimated 600 women c...,s domestic violence shelters. ,, "Our goal is ...
(Date:11/9/2009)... National Ambassador ,, WHITE PLAINS, N.Y., N... Weston, Fla., was born so early and with so many ...hether he would survive -- or if he would ever wal...med March of Dimes 2010 National Ambassador. ,...t minutes of motherhood and I was completely devas...
Breaking Medicine News(10 mins):Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3
...s,International, Inc. (NYSE: WTW ) will release i...YSE close on Thursday, July 31, 2008., The Compan...t at 5:00,p.m. ET. During the conference call, Dav...s from the investment community., Live audio of t...
...l Combat Veterans, WASHINGTON, July 9 Combat vet...er assistance in 39 additional,communities across ...rs,(VA) will develop Vet Centers by fall 2009., "...terans Affairs. "I,m pleased we can expand access ...
...pitals, WASHINGTON, July 9 CNN reported this mor... System (Corpus Christi TX),received overdoses of ...DT,one of the babies has died; another is in criti...Group,s number one,safety measure that it urges al...
... of new lines may be done without destroying embry...- Scientists say they have finally succeeded in de... development stage of a blastomere, or a 4-cell st...& Embryology annual conference in Barcelona, m...
...tion of 50 years of publishing groundbreaking rese...3 papers that highlight pivotal research and signi...rgonomics (HF/E). The entire online issue is avail...ystems, environments, tools, and products. As note...
...8 Led by Anna Catriona Phillips of the University...to a hepatitis A vaccine in young healthy adults a... vaccination in older community-based adults. , ...ession (10 am to 12 pm) or early evening session (...
Other Medicine News:Health News:Weight Watchers Announces Second Quarter 2008 Earnings Conference Call 2Health News:VA Vet Centers Coming to 39 Communities 2Health News:Statement of the Leapfrog Group on Hospital Overdose of Up to 17 Babies at CHRISTUS Spohn 2Health News:New Technique Harvests Stem Cells at Earlier Stage 2Health News:New Technique Harvests Stem Cells at Earlier Stage 3Health News:Human Factors Journal celebrates 50 years 2
(Date:11/9/2009)... /PRNewswire-Asia-FirstCall/ -- American Oriental,... or "AOBO"), a pharmaceutical,company dedicated to...ture and,commercialization of a broad range of pre...oday announced that it plans to release third quar... 2009, after the market closes. , The Com...
(Date:11/9/2009)..., Nov. 9 Par Pharmaceuti...that it has extended the expiration date and incre...d "Modified Dutch Auction" tender offer, in which ...00,000 aggregate principal amount, or up to approx...bordinated Convertible Notes due 2010. ,, The p...
(Date:11/9/2009)...009 Arena Pharmaceutical...results for the third quarter ended September 30, ...ble to common stockholders in the third quarter of...ed to a net loss allocable to common stockholders ...$0.76 per share, and a net loss allocable to commo...
Breaking Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Cancer Gap Between Whites Blacks May Be Biological in Part 50988 1Cancer Gap Between Whites Blacks May Be Biological in Part 50988 2Fat Cell Protein May Reduce Diabetes Risk 50985 1Fat Cell Protein May Reduce Diabetes Risk 50985 2Fat Cell Protein May Reduce Diabetes Risk 50985 3Barilla 28R 29 and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 50982 1Barilla 28R 29 and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 50982 2Barilla 28R 29 and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 50982 3
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: